David Geffen School of Medicine, University of California, Los Angeles Los Angeles, California, United States
Hypercortisolism is increasingly recognized across a broader spectrum of patients, many of whom lack classical physical features but experience significant cardiometabolic complications and increased mortality. This session will provide a focused, literature-based review of emerging evidence, including new data on evolving disease prevalence in high-risk populations, and the emerging diagnostic approaches.
.jpg)
.jpg)
